{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T22:28:13Z","timestamp":1778279293412,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1038\/ncpneph0573","type":"journal-article","created":{"date-parts":[[2007,8,24]],"date-time":"2007-08-24T06:20:49Z","timestamp":1187936449000},"page":"515-520","source":"Crossref","is-referenced-by-count":34,"title":["Acute kidney injury, hyperosmolality and metabolic acidosis associated with lorazepam"],"prefix":"10.1038","volume":"3","author":[{"given":"Tausif","family":"Zar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irfan","family":"Yusufzai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Graeber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncpneph0573_CR1","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1378\/chest.128.3.1674","volume":"128","author":"KC Wilson","year":"2005","unstructured":"Wilson KC et al. (2005) Propylene glycol toxicity: a severe iatrogenic illness in ICU patients receiving IV benzodiazepines: a case series and prospective, observational pilot study. Chest 128: 1674\u20131681","journal-title":"Chest"},{"key":"BFncpneph0573_CR2","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1097\/01.CCM.0000134831.40466.39","volume":"32","author":"AC Arroliga","year":"2004","unstructured":"Arroliga AC et al. (2004) Relationship of continuous infusion lorazepam to serum propylene glycol concentration in critically ill adults. Crit Care Med 32: 1709\u20131714","journal-title":"Crit Care Med"},{"key":"BFncpneph0573_CR3","first-page":"857","volume":"347","author":"ME Mullins","year":"2002","unstructured":"Mullins ME and Barnes BJ (2002) Hyperosmolar metabolic acidosis and intravenous lorazepam. N Engl J Med 347: 857\u2013858","journal-title":"N Engl J Med"},{"key":"BFncpneph0573_CR4","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJM200204183461618","volume":"346","author":"J Tayar","year":"2002","unstructured":"Tayar J et al. (2002) Severe hyperosmolar metabolic acidosis due to a large dose of intravenous lorazepam. N Engl J Med 346: 1253\u20131254","journal-title":"N Engl J Med"},{"key":"BFncpneph0573_CR5","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S0140-6736(03)12326-4","volume":"361","author":"KA Tuohy","year":"2003","unstructured":"Tuohy KA et al. (2003) Agitation by sedation. Lancet 361: 308","journal-title":"Lancet"},{"key":"BFncpneph0573_CR6","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1592\/phco.23.10.1094.32762","volume":"23","author":"NE Yaucher","year":"2003","unstructured":"Yaucher NE et al. (2003) Propylene glycol-associated renal toxicity from lorazepam infusion. Pharmacotherapy 23: 1094\u20131099","journal-title":"Pharmacotherapy"},{"key":"BFncpneph0573_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.4065\/74.3.259","volume":"74","author":"SA Romanski","year":"1999","unstructured":"Romanski SA and McMahon MM (1999) Metabolic acidosis and thiamine deficiency. Mayo Clic Proc 74: 259\u2013263","journal-title":"Mayo Clic Proc"},{"key":"BFncpneph0573_CR8","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1097\/00003246-200005000-00063","volume":"28","author":"HN Reynolds","year":"2000","unstructured":"Reynolds HN et al. (2000) Hyperlactatemia, increased osmolar gap and renal dysfunction during continuous lorazepam infusion. Crit Care Med 28: 1631\u20131634","journal-title":"Crit Care Med"},{"key":"BFncpneph0573_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/toxsci\/23.1.38","volume":"23","author":"KM Morshed","year":"1994","unstructured":"Morshed KM et al. (1994) Acute toxicity of propylene glycol: an assessment using cultured proximal tubule cells of human origin. Toxicol Sci 23: 38\u201343","journal-title":"Toxicol Sci"},{"key":"BFncpneph0573_CR10","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1592\/phco.23.10.1190.32753","volume":"23","author":"M Hayman","year":"2003","unstructured":"Hayman M et al. (2003) Acute tubular necrosis associated with propylene glycol from concomitant administration of intravenous lorazepam and trimethoprim-sulfamethoxazole. Pharmacotherapy 23: 1190\u20131194","journal-title":"Pharmacotherapy"},{"key":"BFncpneph0573_CR11","first-page":"81A","volume":"46","author":"BC Sturgill","year":"1982","unstructured":"Sturgill BC et al. (1982) Renal tubular necrosis in burn patients treated with topical polyethylene glycol [abstract]. Lab Invest 46: 81A","journal-title":"Lab Invest"},{"key":"BFncpneph0573_CR12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0272-6386(97)90577-1","volume":"30","author":"PD Yorgin","year":"1997","unstructured":"Yorgin PD et al. (1997) Propylene glycol-induced proximal renal tubular cell injury. Am J Kid Dis 30: 134\u2013139","journal-title":"Am J Kid Dis"},{"key":"BFncpneph0573_CR13","first-page":"1237","volume-title":"Medical Toxicology","author":"L Yip","year":"2004","unstructured":"Yip L (2004) Other alcohols, glycols, and glycol ethers. In Medical Toxicology, edn 3 1237\u20131239 (Eds Dart RC et al.) Philadelphia: Lippincott Williams & Wilkins"},{"key":"BFncpneph0573_CR14","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1345\/aph.1G083","volume":"39","author":"BW Neale","year":"2005","unstructured":"Neale BW et al. (2005) Propylene glycol-induced lactic acidosis in a patient with normal renal function: a proposed mechanism and monitoring recommendations. Ann Pharmacother 39: 1732\u20131735","journal-title":"Ann Pharmacother"},{"key":"BFncpneph0573_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1081\/CLT-120030942","volume":"42","author":"PG Jorens","year":"2004","unstructured":"Jorens PG et al. (2004) Unusual D-lactic acid acidosis from propylene glycol metabolism in overdose. J Toxicol Clin Toxicol 42: 163\u2013169","journal-title":"J Toxicol Clin Toxicol"},{"key":"BFncpneph0573_CR16","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1097\/00003246-200212000-00021","volume":"30","author":"M Chicella","year":"2002","unstructured":"Chicella M et al. (2002) Propylene glycol accumulation associated with continuous infusion of lorazepam in pediatric intensive care patients. Crit Care Med 30: 2752\u20132756","journal-title":"Crit Care Med"},{"key":"BFncpneph0573_CR17","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1592\/phco.21.13.1140.34611","volume":"21","author":"MJ Cawley","year":"2001","unstructured":"Cawley MJ (2001) Short-term lorazepam infusion and concern for propylene glycol toxicity: case report and review. Pharmacotherapy 21: 1140\u20131144","journal-title":"Pharmacotherapy"},{"key":"BFncpneph0573_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1592\/phco.2006.26.1.23","volume":"26","author":"BJ Barnes","year":"2006","unstructured":"Barnes BJ et al. (2006) Osmolal gap as a surrogate marker for serum propylene glycol concentrations in patients receiving lorazepam for sedation. Pharmacotherapy 26: 23\u201333","journal-title":"Pharmacotherapy"},{"key":"BFncpneph0573_CR19","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1081\/CLT-120006755","volume":"40","author":"DE Brooks","year":"2002","unstructured":"Brooks DE and Wallace KL (2002) Acute propylene glycol ingestion. J Toxicol Clin Toxicol 40: 513\u2013516","journal-title":"J Toxicol Clin Toxicol"},{"key":"BFncpneph0573_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00134-001-1125-1","volume":"28","author":"MG Parker","year":"2002","unstructured":"Parker MG et al. (2002) Removal of propylene glycol and correction of increased osmolar gap by hemodialysis in a patient on high dose lorazepam infusion therapy. Intensive Care Med 28: 81\u201384","journal-title":"Intensive Care Med"},{"key":"BFncpneph0573_CR21","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1213\/00000539-200206000-00039","volume":"94","author":"AH Al-Khafaji","year":"2002","unstructured":"Al-Khafaji AH et al. (2002) Propylene glycol toxicity associated with lorazepam infusion in a patient receiving continuous veno-venous hemofiltration with dialysis. Anesth Analg 94:1583\u20131585","journal-title":"Anesth Analg"}],"container-title":["Nature Clinical Practice Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpneph0573.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneph0573","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneph0573.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T16:18:42Z","timestamp":1684426722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpneph0573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["BFncpneph0573"],"URL":"https:\/\/doi.org\/10.1038\/ncpneph0573","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1098144.552914","asserted-by":"object"}]},"ISSN":["1745-8323","1745-8331"],"issn-type":[{"value":"1745-8323","type":"print"},{"value":"1745-8331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}